Immunopathological manifestations in Kabuki syndrome: a registry study of 177 individuals
- PMID: 31363182
- DOI: 10.1038/s41436-019-0623-x
Immunopathological manifestations in Kabuki syndrome: a registry study of 177 individuals
Abstract
Purpose: Kabuki syndrome (KS) (OMIM 147920 and 300867) is a rare genetic disorder characterized by specific facial features, intellectual disability, and various malformations. Immunopathological manifestations seem prevalent and increase the morbimortality. To assess the frequency and severity of the manifestations, we measured the prevalence of immunopathological manifestations as well as genotype-phenotype correlations in KS individuals from a registry.
Methods: Data were for 177 KS individuals with KDM6A or KMT2D pathogenic variants. Questionnaires to clinicians were used to assess the presence of immunodeficiency and autoimmune diseases both on a clinical and biological basis.
Results: Overall, 44.1% (78/177) and 58.2% (46/79) of KS individuals exhibited infection susceptibility and hypogammaglobulinemia, respectively; 13.6% (24/177) had autoimmune disease (AID; 25.6% [11/43] in adults), 5.6% (10/177) with ≥2 AID manifestations. The most frequent AID manifestations were immune thrombocytopenic purpura (7.3% [13/177]) and autoimmune hemolytic anemia (4.0% [7/177]). Among nonhematological manifestations, vitiligo was frequent. Immune thrombocytopenic purpura was frequent with missense versus other types of variants (p = 0.027).
Conclusion: The high prevalence of immunopathological manifestations in KS demonstrates the importance of systematic screening and efficient preventive management of these treatable and sometimes life-threatening conditions.
Keywords: KDM6A; KMT2D; Kabuki syndrome; immunity.
Similar articles
-
Autoimmune cytopenia and Kabuki syndrome in paediatrics: Insights in 11 patients.Br J Haematol. 2024 May;204(5):1899-1907. doi: 10.1111/bjh.19387. Epub 2024 Mar 3. Br J Haematol. 2024. PMID: 38432067
-
Defects of B-cell terminal differentiation in patients with type-1 Kabuki syndrome.J Allergy Clin Immunol. 2016 Jan;137(1):179-187.e10. doi: 10.1016/j.jaci.2015.06.002. Epub 2015 Jul 17. J Allergy Clin Immunol. 2016. PMID: 26194542 Free PMC article.
-
Identification of KMT2D and KDM6A variants by targeted sequencing from patients with Kabuki syndrome and other congenital disorders.Gene. 2020 Mar 20;731:144360. doi: 10.1016/j.gene.2020.144360. Epub 2020 Jan 11. Gene. 2020. PMID: 31935506
-
Epigenetic control of the immune system: a lesson from Kabuki syndrome.Immunol Res. 2016 Apr;64(2):345-59. doi: 10.1007/s12026-015-8707-4. Immunol Res. 2016. PMID: 26411453 Review.
-
[One novel pathologic variation in KMT2D cause Kabuki syndrome with hearing loss as the main phenotype and related research on types of deafness].Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2019 Sep;33(9):820-824. doi: 10.13201/j.issn.1001-1781.2019.09.006. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2019. PMID: 31446696 Review. Chinese.
Cited by
-
Extremely Low Birth Weight Infant (Gestational Age of 29 Weeks) With Kabuki Syndrome Type I: Case Report and Literature Review.Mol Genet Genomic Med. 2024 Oct;12(10):e70025. doi: 10.1002/mgg3.70025. Mol Genet Genomic Med. 2024. PMID: 39400990 Free PMC article. Review.
-
Case report: Macrophage activation syndrome in a patient with Kabuki syndrome.Front Immunol. 2024 Jul 30;15:1412084. doi: 10.3389/fimmu.2024.1412084. eCollection 2024. Front Immunol. 2024. PMID: 39139573 Free PMC article.
-
KMT2D regulates activation, localization, and integrin expression by T-cells.Front Immunol. 2024 May 3;15:1341745. doi: 10.3389/fimmu.2024.1341745. eCollection 2024. Front Immunol. 2024. PMID: 38765012 Free PMC article.
-
Pattern Recognition of Common Multiple Congenital Malformation Syndromes with Underlying Chromatinopathy.J Pediatr Genet. 2022 Jun 27;13(1):6-14. doi: 10.1055/s-0042-1748019. eCollection 2024 Mar. J Pediatr Genet. 2022. PMID: 38567171 Free PMC article.
-
KMT2D Deficiency Causes Sensorineural Hearing Loss in Mice and Humans.Genes (Basel). 2023 Dec 28;15(1):48. doi: 10.3390/genes15010048. Genes (Basel). 2023. PMID: 38254937 Free PMC article.
References
-
- Niikawa N, Matsuura N, Fukushima Y, et al. Kabuki make-up syndrome: a syndrome of mental retardation, unusual facies, large and protruding ears, and postnatal growth deficiency. J Pediatr. 1981;99:565–569. - DOI
-
- Ng SB, Bigham AW, Buckingham KJ, et al. Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome. Nat Genet. 2010;42:790–793. - DOI
-
- Lederer D, Grisart B, Digilio MC, et al. Deletion of KDM6A, a histone demethylase interacting with MLL2, in three patients with Kabuki syndrome. Am J Hum Genet. 2012;90:119–124. - DOI
-
- Hu D, Gao X, Morgan MA, et al. The MLL3/MLL4 branches of the COMPASS family function as major histone H3K4 monomethylases at enhancers. Mol Cell Biol. 2013;33:4745–4754. - DOI
-
- Miyake N, Koshimizu E, Okamoto N, et al. MLL2 and KDM6A mutations in patients with Kabuki syndrome. Am J Med Genet. 2013;161:2234–2243. - DOI
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
